ASSESSMENT OF COUMARIN LEVELS IN CINNAMON SPICES AVAILABLE IN THE TURKISH MARKET
Abstract
Objective: Cinnamon has been widely used as a popular spice. The cheaper and more commonly found Cassia cinnamon contains high amounts of coumarin, a naturally occurring hepatotoxic component. The coumarin content added to food products for flavoring purposes is regulated by the European Food Safety Authority. Therefore, it is important to know the amount of coumarin in commercial cinnamon spices and to determine the consumption amounts.
Material and Method: In this study, 22 samples labeled as cinnamon in stick and ground form in the Turkish markets were analyzed using LC-qTOF-MS. The analyzed coumarin content was compared to the European Union limit, which is the tolerable daily intake set by the European Food Safety Authority at 0.1 mg coumarin/kg body weight.
Result and Discussion: The results showed that all but one of the samples contained coumarin. Considering the daily intake limits of coumarin, which are a maximum of 1.5 mg for a 15 kg child and 6 mg for a 60 kg adult, it was found that most samples exceeded these limits. In addition to the amount of coumarin and daily intake that people should be cautious about when consuming cinnamon, the type of cinnamon, whether in stick or powder form, should also be indicated on cinnamon spice packages.
Keywords
References
- 1. Yazdanpanah, Z., Azadi-Yazdi, M., Hooshmandi, H., et al. (2020). Effects of cinnamon supplementation on body weight and composition in adults: A systematic review and meta-analysis of controlled clinical trials. Phytotherapy Research, 34(3), 448-463. [CrossRef]
- 2. Bandara, T., Uluwaduge, I., Jansz, E.R. (2012). Bioactivity of cinnamon with special emphasis on diabetes mellitus: A review. International Journal of Food Sciences and Nutrition, 63, 380-386. [CrossRef]
- 3. Rafehi, H., Ververis, K., Karagiannis, T.C. (2012). Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes, Obesity and Metabolism, 14, 493-499. [CrossRef]
- 4. Sierra-Puente, S., Abadi-Alfie, S., Arakanchi-Altaled, K., et al. (2020). Cinammon (Cinnamomum spp.) and type 2 diabetes mellitus. Current Topics in Nutraceutical Research, 18(3), 247-255.
- 5. World Health Organization. WHO. (1999). Cortex Cinnamomi. WHO Monographs on Selected Medicinal Plants,1, Geneva, 95-105.
- 6. Ravindran, P.N., Nirmal-Babu, K. (2004). Introduction. Eds.: Ravindran, P.N., Nirmal-Babu, K., Shylaja, M. Cinnamon and Cassia: The Genus Cinnamomum, CRC Press, Boca Raton, 1-13.
- 7. Wang, Y.H., Avula, B., Dhammika Nanayakkara, N.P., et al. (2013). Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States. Journal of Agricultural and Food Chemistry, 61, 4470-4476. [CrossRef]
- 8. Sproll, C., Ruge, W., Andlauer, C., et al. (2008). HPLC analysis and safety assessment of coumarin in foods. Food Chemistry, 109, 462-469. [CrossRef]
Details
Primary Language
English
Subjects
Pharmaceutical Botany
Journal Section
Research Article
Authors
Ozan Kaplan
0000-0001-7429-9349
Türkiye
Gurbet Ünal Özen
0000-0002-3789-7419
Türkiye
Mustafa Çelebier
0000-0001-7712-5512
Türkiye
Early Pub Date
May 15, 2026
Publication Date
-
Submission Date
August 16, 2025
Acceptance Date
April 11, 2026
Published in Issue
Year 2026 Number: Advanced Online Publication